Literature DB >> 1370955

Osteofibrous dysplasia of long bones--a reactive process to adamantinomatous tissue.

Y Ueda1, S Blasius, G Edel, P Wuisman, W Böcker, A Roessner.   

Abstract

The most controversial aspect of osteofibrous dysplasia (OFD) is its possible histogenetic relationship to adamantinoma of long bone. Evidence is recently beginning to accumulate that OFD may be a reactive process to regressive adamantinoma. To verify the concept, 13 lesions of OFD were studied again by immunohistochemistry for cytokeratins of different molecular masses, as well as by conventional stainings. In addition, 2 adamantinomas and 6 fibrous dysplasias of the tibia were studied for reference. A small number of spindle- or ovoid-shaped cells scattered individually in the fibro-osseous stroma showed positive reactions for cytokeratins of 55-57 kDa in 2 lesions, and for those of 45-56.5 kDa in 8 lesions of 13 OFDs, although no definite epithelial island could be detected even by immunohistochemistry. Adamantinomas also showed single cytokeratin-positive cells dispersed in fibroblastic stroma, in addition to epithelial islands positive for cytokeratins of both 55-57 kDa and 45-56.5 kDa. All cases of fibrous dysplasia were negative for cytokeratins. During the observation, no case of OFDs progressed to classic adamantinoma. The present study, demonstrating the existence of an intermediate stage between "differentiated adamantinoma" and total elimination of adamantinomatous components, gives further support for the concept that OFD is a secondary reactive process to adamantinomatous tissue. In practice, the existence of single scattered cytokeratin-immunoreactive cells in otherwise typical OFDs may not indicate the truly malignant behaviour of classic adamantinoma, unless discrete epithelioid cell nests are also found.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370955     DOI: 10.1007/bf01187505

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

Review 1.  Juvenile intracortical adamantinoma of the tibia with predominant osteofibrous dysplasia-like features.

Authors:  Y Ueda; A Roessner; A Bosse; G Edel; W Böcker; P Wuisman
Journal:  Pathol Res Pract       Date:  1991-12       Impact factor: 3.250

2.  Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen.

Authors:  W W Franke; R Moll
Journal:  Differentiation       Date:  1987       Impact factor: 3.880

3.  Adamantinoma of long bones. A clinicopathologic study of 85 cases.

Authors:  G L Keeney; K K Unni; J W Beabout; D J Pritchard
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

4.  Coexpression of intermediate filament polypeptides in human fetal and adult tissues.

Authors:  G N Van Muijen; D J Ruiter; S O Warnaar
Journal:  Lab Invest       Date:  1987-10       Impact factor: 5.662

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  Ossifying fibroma of the long bones. A light and electron microscopic study.

Authors:  R L Kempson
Journal:  Arch Pathol       Date:  1966-09

7.  Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia.

Authors:  B Czerniak; R R Rojas-Corona; H D Dorfman
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

8.  Osteofibrous dysplasia of long bones a new clinical entity.

Authors:  M Campanacci
Journal:  Ital J Orthop Traumatol       Date:  1976-08

9.  Immunohistochemical demonstration of epithelial differentiation in adamantinoma of the tibia.

Authors:  J Rosai; G S Pinkus
Journal:  Am J Surg Pathol       Date:  1982-07       Impact factor: 6.394

10.  Osteofibrous dysplasia of the tibia and fibula.

Authors:  M Campanacci; M Laus
Journal:  J Bone Joint Surg Am       Date:  1981-03       Impact factor: 5.284

View more
  6 in total

Review 1.  Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma.

Authors:  Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2003-03-22       Impact factor: 2.199

2.  p63 expression in adamantinoma.

Authors:  Brendan C Dickson; Yair Gortzak; Robert S Bell; Peter C Ferguson; David J C Howarth; Jay S Wunder; Rita A Kandel
Journal:  Virchows Arch       Date:  2011-06-15       Impact factor: 4.064

3.  Polyostotic lesions compatible with osteofibrous dysplasia. A case report.

Authors:  T Ozaki; M Hamada; K Taguchi; Y Nakatsuka; S Sugihara; H Inoue
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

4.  Treatment of osteofibrous dysplasia and associated lesions.

Authors:  Soo Bong Hahn; Sung Hun Kim; Nam Hoon Cho; Chul Jun Choi; Bom Soo Kim; Ho Jung Kang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

5.  Adamantinoma: a clinicopathological review and update.

Authors:  Deepali Jain; Vijay K Jain; Rakesh K Vasishta; Prabhat Ranjan; Yashwant Kumar
Journal:  Diagn Pathol       Date:  2008-02-15       Impact factor: 2.644

6.  Giant monostotic osteofibrous dysplasia of the ilium: A case report and review of literature.

Authors:  Yu-Bo Liu; Tian-Ming Zou
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.